Delivery Order SPE2DB20D2002-SPE2DB24FL07C
- Not listed
- This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,226.41 and is a Firm Fixed Price Delivery Order that runs through October 30, 2023. The contract was awarded on October 27, 2023...
- This federal contract award is for the delivery of the PEDVAXHIB vaccine vial 0.5ML to the Defense Logistics Agency (DLA). The $1,718.45 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of July 27, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA). The $1,752.30 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of September 25, 2023 and was awarded on September 22, 2023. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,401.84, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 8, 2023. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of August 9, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PEDVAXHIB vaccine vials. The contract, valued at $1,051.38, is a Firm Fixed Price Delivery Order that has an ultimate completion date of October 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order for the PEDVAXHIB vaccine vial, 0.5ML, awarded to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The award has a ceiling value of $5,256.90 and an ultimate completion date of January 26, 2023. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on January 25, 2023. The contract type is Firm Fixed Price, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a prime contractor for the U.S. government. The contract has a ceiling value of $7,758.87 and is a Firm Fixed Price Delivery Order with a completion date of June 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award is a delivery order worth $1,897.18 for the supply of PEDVAXHIB Vaccine vials, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on March 16, 2023, with a completion date of March 17, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award from the Defense Logistics Agency (DLA) is a $2,379.46 firm fixed-price delivery order for the PEDVAXHIB vaccine vial (0.5 ml) placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award is for the delivery of PEDVAXHIB vaccine vials (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $1,413.47, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 18, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB24FL07CDelivery Order
This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $1,455.07, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of December 5, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a for-profit organization. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/4/23 |